ons in surgery, including the first intrauterine procedure to relieve pressure on the brain of a hydrocephalic fetal twin, and for resurrecting the procedure for cerebral hemispherectomy (the removal of half the brain) to alleviate uncontrollable seizures, of which he has performed more than 100. He made medical history in 1987 when he became the first surgeon to successfully separate occipital craniopagus twins, and was involved in several other subsequent separations. In 2008, President George W. Bush
awarded Dr. Carson the Presidential Medal of Freedom, the nation's highest civilian honor.
"Vaccinogen is the first company to have developed an approach that uses the patient's own colon cancer tumor cells to 'train' the body's immune system to attack residual cancer cells and prevent recurrence of this disease which is plagued by genetic mutations that make one-size-fits-all therapies ineffective or toxic for most patients," Dr. Vermorken said. "I believe that Vaccinogen's unique processes, which include proprietary cell sterilization techniques, have the potential to fundamentally change the way we treat cancer. I'm honored to have not only worked directly with this therapy for much of my career but also to now become a part of the medical advisory board."
Dr. Vermorken was the principal investigator of the first Phase III clinical trial for OncoVAX in the treatment of colon cancer.
Dr. Vermorken's main research areas include early clinical and pharmacological studies with new drugs; studies on the interaction of chemotherapy and radiation therapy; research into the links between human papillomavirus (HPV) and various malignancies; and clinical investigation of new immunological approaches. He is Emeritus Professor of Oncology at the University of Antwerp and past head of the department of oncology at the Antwerp University Hospital. In March 2013, he was awaPage: 1 2 3 4 Related biology technology :1
. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer2
. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List3
. Rhythm Names Lex Van der Ploeg Chief Scientific Officer4
. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer5
. Codexis Names Wes Bolsen VP and Chief Marketing Officer6
. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent7
. Fitzsimons Redevelopment Authority Names New President & CEO8
. Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President9
. Laureate Biopharma Names James D. Utterback to Board of Directors10
. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture11
. Hospira Names John B. Elliot Senior Vice President of Operations